Page 10 - Surgical Sciences News Today

A woman was treated for severe facial skeletal deformities caused by the condylar resorption of her temporomandibular joint, according to a report.

SubmitTed VANDERBILT — The Vanderbilt Transplant Center performed a record number of solid organ transplants in fiscal year 2021 — 637 life-saving procedures among its adult and pediatric programs — despite occurring entirely during the COVID-19 pandemic. The total number of transplants from the period between July 2020 and the end of June 2021, are up 10% from the 578 transplants during the same period in fiscal year 2020. In fiscal year 2021, Vanderbilt University Medical Cente...

 E-Mail Men over 60 with low-risk prostate cancer could spend ten years with no active treatment, have a better sex life as a result, yet still be very unlikely to die from the disease, new research has found. The findings come from two new studies looking at active surveillance of prostate cancer - when the disease is closely monitored but not treated - presented at the European Association of Urology congress, EAU21, today. The first uses data from Swedens National Prostate Cancer Register, ...

5th July 2021 12:02 am 2nd July 2021 11:14 am Artificial intelligence is being used to help detect early signs of oesophageal cancer, a disease with a five-year survival rate of under 20 per cent. Image: UCL The first procedure in the world using the so-called CADU AI technology was performed at University College Hospital by UCLH consultant gastroenterologist Dr Rehan Haidry. CADU achieved regulatory approval at the start of 2021 making it the first medical device using AI for oesophageal ...

University of Otago releases commercial version of DIVA clinical auditing tool Written by Kate McDonald on 04 February 2021. The University of Otago’s Department of Surgical Sciences has released a commercial version of its DIVA clinical auditing tool, allowing medical staff to input and monitor information on patients during their surgical visit. DIVA records every patient, operation, diagnosis and complication and promises to make it easy to conduct clinical audit and peer r...

Acer Therapeutics Announces Publication of Vascular Ehlers-Danlos Syndrome (vEDS) Patient Registry Data from Sweden Acer Therapeutics Announces Publication of Vascular Ehlers-Danlos Syndrome (vEDS) Patient Registry Data from Sweden NEWTON, Mass., Dec. 17, 2020 — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today anno...